FDA Approves a Drug That Can Delay Type 1 Diabetes
The therapy will cost nearly $200,000. But it ’s the first treatment in 100 years to alter the course of the disease, which usually begins in adolescence.
Source: NYT Health - Category: Consumer Health News Authors: Gina Kolata Tags: Diabetes Drugs (Pharmaceuticals) Immune System Insulin Food and Drug Administration Sanofi SA Immunotherapy Provention Bio Inc Source Type: news
More News: Diabetes | Diabetes Type 1 | Endocrinology | Food and Drug Administration (FDA) | Health | Immunotherapy | Insulin